RESMED INC — Director's Dealing 2025

Aug 19, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2025-08-18

Reporting Person: Hernandez John (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2025-08-18	ResMed Common Stock	M	2575	$148.90	Acquired	6620	Direct
2025-08-18	ResMed Common Stock	S	2575	$287.1026	Disposed	4045	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2025-08-18	ResMed Common Stock Options	$148.90	M	2575	Disposed	2030-11-16	ResMed Common Stock (2575)	Direct

Footnotes

F1: This transaction was executed in multiple trades at prices ranging from $286.90 - $287.24. The price reported above reflects the weighted average sale price.

F2: Represents the date options become exercisable. Options vest in full (i) on the first Nov. 11 following the grant date or (ii) the first annual shareholders meeting following grant date.